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Abstract
A Papua New Guinea field collection of the marine cyanobacterium Blennothrix cantharidosmum
was investigated for its cytotoxic constituents. Bioassay-guided isolation defined the cytotoxic
components as the known compounds lyngbyastatins 1 and 3. However, six new acyl proline
derivatives, tumonoic acids D-I, plus the known tumonoic acid A, were also isolated. Their planar
structures were defined from NMR and MS data while their stereostructures followed from a series
of chiral chromatographies, degradation sequences and synthetic approaches. The new compounds
were tested in an array of assays, but showed only modest antimalarial and inhibition of quorum
sensing activities. Nevertheless, these are the first natural products to be reported from this genus,
and this inspired a detailed morphologic and 16S rDNA-based phylogenetic analysis of the producing
organism.
Cyanobacteria are an ancient group of organisms well known for their prolific production of
natural products.1,2 Several genera, such as Lyngbya and Microcystis, have been well
investigated for production of both dangerous toxins and drug leads.3,4 However, there are
numerous other cyanobacterial genera that have not been studied in such detail. Recent
advances in the molecular taxonomy of cyanobacteria have allowed more rapid and precise
identification of cyanobacterial specimens and have the potential to assist in the discovery of
new natural products from some of these lesser-known genera.
Blennothrix cantharidosmum Komárek (formerly Hydrocoleum Gomont) is one of the most
abundant species of mat-forming benthic cyanobacteria in the tropics5 and an important
contributor to nitrogen fixation.6 Under bacteriological systems, Blennothrix has been assigned
as a sub-genus of Microcoleus based on several common morphological features, most
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distinctively, the presence of multiple trichomes within a single sheath.7 However, recent
phylogenetic studies have shown that Blennothrix species are more closely related to the
common planktonic genus Trichodesmium.5,8 Despite their widespread occurrence, very few
studies have been carried out on the chemistry of Blennothrix, and these studies have focused
solely on their pigments.5,9 In this manuscript, we describe the first secondary metabolites
reported from a Blennothrix species, and further investigate the taxonomy of this important
genus of marine cyanobacterium.
Results and Discussion
Natural products isolation and structure elucidation
The strain was collected near Duke of York Island in Papua New Guinea in 2005. The specimen
was extracted with CH2Cl2– MeOH, and fractionated by silica vacuum liquid chromatography.
Initial assays revealed activity against an H-460 cell line in several of the polar fractions, which
were subsequently fractionated by reversed-phase solid phase extraction (SPE) and HPLC to
yield the known metabolites lyngbyastatins 110 and 311 as the active metabolites, in addition
to six new acylproline derivatives, the tumonoic acids D-I (1-6), as well as the known
compound tumonoic acid A (7).12 Structures of the tumonoic acids are given in Figure 1.
The molecular formula of tumonoic acid D (1) was determined to be C16H29NO3 by HRESIMS
(m/z 284.2211, [M+H]+). Analysis of 1H NMR data (Table 1) revealed downfield resonances
(δH 4.64, d; 3.62, ddd; 3.51, ddd) characteristic of a proline residue, while the large methylene
envelope (δH 1.24–1.28) and methyl signals (δH 1.15, d; 0.88, t) suggested a branched fatty
acid. HMBC correlations from the methyl doublet to carbons at 179.9, 38.1 and 34.1 ppm
confirmed its location at C-2. 2D NMR analysis (Figure 2) enabled the assignment of all protons
and carbons in the proline residue, and the terminal regions of the fatty acid moiety. The three
remaining carbons (δC 29.2, 29.4, 29.6) were assigned as the methylene carbons in the central
portion of the fatty acid, which was consistent with the observed molecular formula. However,
no HMBC correlations were observed linking the proline and fatty acid portions of 1, but based
on the downfield shifts of H-2′ and H-5′, it was clear that the proline nitrogen was part of an
amide group, leading to the structure shown.
Tumonoic acid E (2) (C18H31NO4, m/z 326.2321, [M+H]+) possessed more complex 1H
and 13C NMR spectra than 1. While resonances consistent with a proline residue were present,
it was clear that the fatty acid moiety of 2 was more highly functionalized. The presence of a
downfield doublet (δH 5.23, d), along with two sp2 carbon resonances (δC 137.0, 132.3),
suggested the presence of a double bond. Also observed were resonances consistent with an
oxygenated methine (δH 4.15, d; δC 80.6), and two additional methyls. A broad IR stretch at
3381 cm-1 confirmed the presence of a free hydroxy group. COSY and HMBC correlations
(Figure 2) situated the oxygenated methine at H-3, while HMBC correlations from the three
methyl groups (δH 1.05, d; δC 14.3, δH 1.63, brs; δC 10.9, and δH 0.95, d; δC 20.9) confirmed
their positions at C-2, C-4, and C-6, respectively. Likewise, HMBC correlations situated the
vinylic proton at H-5, while ROESY correlations between H-5 and H-3 confirmed the E-
geometry of the double bond. The H-2 pentet (δH 2.82, dq, J = 6.8, 6.5) of the fatty acid moiety
was characteristic for an anti-configuration of the 2-Me and 3-OH substituents.12,13 The
relative configuration at C-6 was not assigned.
Tumonoic acid F (3) (C21H37NO5, m/z 384.2736, [M+H]+) also possessed a complex fatty acid
moiety, two secondary methyls (δH 1.14, d and 0.91, d) and an oxygenated methine proton
(δH 5.21, d) shifted further downfield than that of 2. In combination with the presence of a
deshielded methyl group (δH 1.99, s; δC 20.8) and an additional carbonyl resonance (δC 169.9),
this suggested the presence of an O-acetyl group at C-3, which was confirmed by 2D NMR
analysis (Figure 2). HMBC correlations also positioned the secondary methyls at C-2 and C-4,
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respectively. As for 2, the H-2 pentet of the fatty acid moiety suggested an anti-arrangement
for the 2-Me and 3-OAc moieties. In an attempt to determine the absolute configuration at C-3,
a small sample of 3 was subjected to base hydrolysis and derivatization with Mosher's acid
chloride (both R and S). However, this proved unsuccessful. Prior research has suggested that
reduction of the C-1 amide to an alcohol is necessary before successful esterification can occur.
12 Given the small amount of material available, further attempts were not made.
The molecular formula of tumonoic acid G (4) was determined to be C25H43NO7 (m/z
470.3106, [M+H]+) by HRESIMS. While 1H and 13C NMR analyses revealed the presence of
the same proline and 2-methyldecanoyl moieties as tumonoic acid D (1), the spectra were
significantly more complex, with additional downfield methine and methyl resonances being
the most distinctive new elements. COSY analysis established the presence of a spin system
incorporating two methines (δH 5.05, d; δH 2.05, m), two methyls (δH 0.91, t; δH 0.96, d), and
a diastereotopic methylene unit (δH 1.44, m; δH 1.28, m), consistent with the presence of an
isoleucic acid residue. 13C NMR shifts (Table 2) and HMBC correlations (Figure 2) confirmed
this assignment, and a strong correlation from H-2″ to C-1 of the proline residue was used to
connect the isoleucic acid to the proline unit. The second new spin system consisted of another
downfield methine connected to a deshielded methyl resonance. While no HMBC correlations
were observed from these protons, the distinctive chemical shifts (δH 5.27, brq; δC 71.1 and
δH 1.50, d; δC 16.7) were indicative of a lactic acid residue, which was later confirmed by
HPLC analysis as described below. The terminal carboxylic acid group was not observed in
the 13C NMR spectrum, likely due to broadening caused by partial deprotonation of this
functionality.
The 1H and 13C NMR spectra of tumonoic acid H (5) (C26H45NO7, m/z 484.3254, [M+H]+)
were very similar to those of 4, with the same proline and 2-methyldecanoyl units again present,
however, the abundance of secondary methyls (δH 1.00, d; 1.00, d; 0.99, d; 0.98, d) indicated
the presence of two 2-hydroxyisovaleric acid residues in place of the isoleucic and lactic acids
of 4. 2D NMR analysis (Figure 2) was consistent with such a structure, and later chiral HPLC
analysis confirmed the presence of the hydroxyisovaleric acid residues.
Likewise, tumonoic acid I (6) (C27H47NO7, m/z 498.3413, [M+H]+) was very similar to both
4 and 5. A second set of resonances characteristic of isoleucic acid (Table 2) indicated the
replacement of the lactic acid residue of 4 with an additional isoleucic acid residue. Compound
6 showed a much smaller methylene envelope than that of the other tumonoic acids, indicating
the presence of a shorter fatty acid chain. Additionally, a distinctive secondary methyl
resonance (δH 0.88, d; δC 20.1) indicated the presence of a second methyl branch along the
fatty acid chain; this could be positioned at C-4 using 2D NMR correlations to give the structure
shown (Figure 2). Based on the wide separation of the 1H NMR resonances (δH 1.64, 1.19) of
H-3 of the dimethyloctanoic acid moiety, and comparison with literature examples, we propose
that the C-2 and C-4 methyl groups are in a syn-orientation.14
Stereochemical investigations
After solving the planar structures of 1-6, the next issues to be addressed were their absolute
configurations. This was determined for the proline residues of 1-7 by acid hydrolysis followed
by derivatization with Marfey's reagent (FDVA) and subsequent LCMS analysis. This analysis
revealed that the proline unit in all seven compounds was L. The configurations of the α-hydroxy
acids of 4-6 were determined by chiral HPLC. Analysis of the acid hydrolysates of 4-6 and
comparison with known standards revealed the following compositions: 4: D-allo-isoleucic
acid, L-lactic acid; 5: D-2-hydroxyisovaleric acid, L-2-hydroxyisovaleric acid; 6: D-allo-isoleucic
acid, L-isoleucic acid. In order to determine the positions of the isomeric hydroxy acids in 5
and 6, the natural products were derivatized with α-methylbenzylamine and the products
subjected to base hydrolysis, yielding only one free hydroxy acid. Analysis of these
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hydrolysates revealed only D-2-hydroxyisovaleric acid for 5 and D-allo-isoleucic acid for 6,
enabling the configurations of the hydroxy acids to be assigned as shown.
The C-2 configuration of the fatty acid moiety of tumonoic acid D (1) was determined by
synthesis. Racemic 2-methyldecanoic acid was first derivatized with L-proline methyl ester.
The methyl ester present in each component of the mixture was hydrolyzed under basic
conditions to yield two epimeric acids 1 and 8. These were separated using reversed-phase
(RP) HPLC and characterized using standard spectroscopic techniques. 1H and 13C NMR, IR
and [α]D data were very similar for both epimers, and it was not possible to conclusively
distinguish the two solely on this basis. However, co-injections of the synthetic epimers with
natural 1 and analysis by LCMS conclusively showed that the earlier eluting peak was the
natural epimer. Finally, each of the two synthetic tumonoic acids was hydrolyzed under acidic
conditions to give free 2-methyldecanoic acid, which was purified by HPLC and its [α]D value
measured and compared with literature values.15 This sequence revealed that 1 contained
(2S)-2-methyldecanoic acid whereas the unnatural epimer 8 incorporated (2R)-2-
methyldecanoic acid. Although we did not conduct similar reaction sequences on the other new
tumonoic acids, we propose on biogenetic grounds that 4 and 5 share the same absolute
configuration at C-2. As the known tumonoic acid A (7) possesses the opposite 2R
configuration, we have not assigned the absolute configurations of the fatty acid portions for
2, 3, or 6. Intriguingly, our isolate of tumonoic acid A (7) was of 2R configuration as in the
original report {[α]D -79.4 (c 0.3, CHCl3); lit. [α]D -79 (c 1.1, CHCl3)12}, and this is opposite
the configuration at C-2 in compound 1.
Tumonoic acids A-C were originally isolated in 1999 along with two methyl esters, and were
not reported to possess any significant biological activities.12 The new tumonoic acids differ
from these previously isolated examples in the greater diversity of fatty acids incorporated. All
three tumonoic acids in the original isolation possess the same 2,4-dimethyl-3-
hydroxydodec-4-enoic acid moiety, while those in the current study include a range of unusual
fatty acids.
Biological activities
The tumonoic acids A (7) and D-I (1-6) were assayed for anticancer, antimalarial, anti-Chagas,
antileishmania, and antimicrobial (MRSA) activity. Tumonoic acid I (6) displayed moderate
activity in the antimalarial assay (IC50 = 2 μM) whereas none of the other naturally occurring
analogs showed any activity in this assay at a concentration of 10 μg/mL. It was interesting to
observe only 6 displaying such activity given the strong structural similarities between 6 and
the other isolated acids, especially 4 and 5. It was also noted that several of these tumonoic
acids bore a close resemblance to homoserine lactones involved in bacterial communication.
Thus, investigations were carried out into the possible effects of these compounds on bacterial
quorum sensing and biofilm formation. The tumonoic acids showed no activity in an assay
utilizing a mutated E. coli strain that produces green fluorescence protein in response to 3-
oxohexanoyl homoserine lactone addition.16 However, in an assay using a wild-type strain of
Vibrio harveyi that regulates bioluminescence via quorum sensing, several of these tumonoic
acids (2-5) displayed modest inhibition of bioluminescence without affecting bacterial growth,
with tumonoic acid F (3) being the most active (IC50 of 62 μM).
Morphological and phylogenetic analysis
Given the difficulties in the taxonomic classification of cyanobacteria, and relative paucity of
16S rDNA sequences for Blennothrix species in the literature, a detailed morphological and
phylogenetic analysis of Blennothrix strain PNG05-4 (PNG-5/21/05-4) was carried out. The
strain was morphologically identified as B. (Hydrocoleum) cantharidosmum Komárek &
Anagnostidis. The thallus formed a soft, gelatinous, thick, 2 cm high, brown/grey mat covering
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the reef substrate. The cyanobacterium was filamentous and filaments were either solitary or
several enclosed together in common sheaths. Furthermore, the trichomes were cylindrical and
slightly constricted at the crosswalls. Cells were disk-shaped, 21 μm wide and 3.1 μm long.
The end cells were cylindrical, with thickened outer cell walls.
The almost complete 16S rDNA gene sequence (1414 nucleotides) was PCR-amplified and
sequenced (GenBanck Acc. No. EU253968). BLAST-analysis of the 16S rDNA gene sequence
showed highest sequence identity (99.1%) with the B. (Hydrocoleum) cantharidosmum strain
GV58 from New Caledonia (GenBank Acc. No. DQ883636).5 Due to the lack of full 16S
rDNA sequences for related species available in databases, including the Blennothrix sp. from
New Caledonia, a 1082 nucleotide stretch of the 16S rDNA genes was used in the final multiple
sequence alignment and phylogenetic tree construction. The three main kinds of reconstruction
methods [(1) the distance method by neighbour-joining (NJ), (2) maximum parsimony (MP),
and (3) likelihood method by maximum-likelihood (ML)] were compared for their predicted
relationships. The overall topography of the different phylogenetic trees was consistent with
the ML-method giving the most robust bootstrap values; hence, this tree is displayed in Figure
3. The clading was also stable using either the 1414- or the 599-nucleotide stretches (see
Supporting Information); however, use of the 1414 base pair stretch excluded several species
of interest in the study. In the final phylogenetic analysis, 43 16S rDNA cyanobacterial gene
sequences were included, including four from Microcoleus species. Consistent with previous
findings,5 species of Blennothrix and Microcoleus are genetically very different and form
separate clades in the phylogenetic tree.
Schizothrix is a former genus that has also been assigned as a sub-genus of Microcoleus based
on the presence of multiple trichomes within a sheath,7 and thus it bears a close resemblance
to Blennothrix. However, the 16S rDNA gene data for Schizothrix species available in GenBank
is even less extensive than that for Blennothrix, with only a 599 nucleotide stretch being
currently available (Schizothrix calcicola UTEX, GenBank Acc. No. AY271841). Hence, in
the interests of further clarifying the taxonomic relationships between these genera, a
Schizothrix sp. PNG5-22 (PNG-5/20/05-2) from our own collection was morphologically- and
phylogenetically-identified according to previously described taxonomic methods, and its 16S
rDNA gene sequence was also included in this study. The thallus of this specimen was soft,
mucilaginous, hemispherical, 4 cm tall, and dark yellowish-brown. The cyanobacterium was
filamentous, with several cylindrical trichomes within the same sheaths. The cells were
isodiametric, 1.2 μm wide by 3.2 μm long.
A 1370 nucleotide stretch of the Schizothrix PNG5-22 16S rDNA gene was PCR-amplified
and sequenced (GenBank Acc. No. 1060443), and a 1082-nucleotide stretch included in the
phylogenetic analysis described above. Interestingly, this Schizothrix sp. PNG5-22 appeared
genetically very different from members of both Microcoleus and Blennothrix (Figure 3). Thus,
it appears that the taxonomic groupings originally created using phycological criteria and
nomenclature are supported by this genetic-based analysis, and raises concerns about the recent
regrouping of genera under the bacteriological system.7
Conclusions
The tumonoic acids were originally isolated from a Lyngbya majuscula/Schizothrix
calcicola assemblage, as well as a collection of L. majuscula, all collected in Guam.12 Given
the uncertainties involved in cyanobacterial taxonomy, and the overall morphological
resemblance between Blennothrix, Schizothrix and Lyngbya, it is possible that the original
tumonoic acid isolation was in fact from a Lyngbya/Blennothrix assemblage.17 However, in
the absence of 16S rDNA data from the previous work it is impossible to make a definitive
assignment. The current study illustrates the inadequacy of morphological identification in
cyanobacterial taxonomy, and demonstrates the complementary power of molecular-taxonomy
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in the classification of these organisms. Precise taxonomic investigations are important in
guiding chemical investigations of some of the less well studied cyanobacteria, and these can
lead to the isolation of new metabolites such as those described herein.
Experimental Section
General Experimental Procedures
Optical rotations were measured on a JASCO P1010 polarimeter. IR and UV spectra were
recorded on a Nicolet IR-100 FT-IR and Beckman-Coulter DU800 spectrophotometer,
respectively. NMR spectra were recorded on Varian Unity 300 and 500 MHz spectrometers
with the solvent CDCl3 (δH at 7.26, δC at 77.0) used as an internal standard. High resolution
mass spectra were acquired using an Agilent ESI-TOF mass spectrometer. LC-MS analyses
were carried out on a Finnigan LCQ advantage mass-spectrometer, attached to a Finnigan
Surveyor HPLC system. HPLC was performed using Waters 515 pumps and a Waters 996
photodiode array detector, under computer control using Empower software. Chemicals were
acquired from VWR, except for 2-methyldecanoic acid, which was purchased from Narchem,
and 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDAC.HCl), purchased
from Chem-Impex International.
Collection
The Blennothrix and Schizothrix specimens were collected by SCUBA in Papua New Guinea
in May 2005. The Blennothrix sp. PNG05-4 (PNG-5/21/05-4) was collected to the west of
Duke of York Island, near Kibil, at a depth of 30 ft (GPS coordinates S 04° 07.270′, E 152°
26.666′). The Schizothrix sp. PNG5-22 (PNG-5/20/05-2) was collected on a reef to the west
of the Credner islands, near Kerawara, at a depth of 40 ft (GPS coordinates S 04° 12.922′, E
152° 22.926′). The samples were stored in EtOH-seawater (1:1) at −20 °C until extraction, with
a small (∼100 mg) tissue sample preserved in 5 mL RNA-later (Ambion®) for genetic analysis.
Voucher specimens are available from WHG.
Morphological Characterization
Preliminary morphological and taxonomic characterizations of the Blennothrix and
Schizothrix specimens were performed using a field microscope (RFM-2 Microscope from
Richardson Technologies Inc.) and the taxonomic field guide by Littler & Littler,18 while more
accurate measurements and characterizations were made with an Olympus BH-2 light
microscope. The following morphological parameters were evaluated: thallus morphology,
cell length, cell width (and cell length/width ratios), constriction of cell walls, presence of
specialized cells such as heterocysts, akinetes or calyptra, size and shape of trichomes, and
characteristics of end-cells. Morphological identification was made in accordance with the
phycological systems by Gomont,19 Geitler,20 and Komárek & Anagnostidis.21
DNA Extraction, 16S rDNA Gene PCR-amplification and Cloning
Genomic DNA was extracted from 40 mg of cleaned cyanobacterial tissues using the Wizard®
Genomic DNA Purification Kit (Cat. A1120) according to the manufacturer's specifications
(Promega, Madison, WI). The isolated genomic DNA was further purified using Genomic-tips
20/G from Qiagen® (Cat. 10223). The 16S rDNA genes were PCR-amplified from isolated
DNA using the cyanobacteria-specific primers, 106F and 1509R, as previously described.22
The reaction volumes were 25 μL containing 0.5 μL of DNA (50 ng), 2.5 μL of 10× PfuUltra
II reaction buffer, 0.5 μL of dNTP mix (25 mM each of dATP, dTTP, dGTP, and dCTP), 0.5
μL of each primer (10 μM), 0.5 μL of PfuUltra II fusion HS DNA polymerase (Cat. 600760)
and 20.5 μL dH2O. The PCR reaction was performed in an Eppendorf® Mastercycler® gradient
as follows: initial denaturation for 2 min at 95°C, 30 cycles of amplification using: 20 sec at
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95°C, 20 sec at 50°C (16S rDNA)/56°C (ITS) and 15 sec at 72°C, and final elongation for 3
min at 72°C. PCR products were subcloned using the Zero Blunt® TOPO® PCR Cloning Kit
(Cat. K2800-20SC) from Invitrogen into pCR®-Blunt II TOPO® vector, transformed into
TOPO® cells and cultured on LB-Kanamycin plates. Plasmid DNA was isolated using the
QIAprep® Spin Miniprep Kit (Cat. 27106) from Qiagen and sequenced in both directions using
pCR®-Blunt II TOPO® vector specific primers M13F and M13R and the internal middle
primers 359F and 758R as previously described.22
Phylogenetic Analysis
The 16S rDNA gene sequences were visually inspected and a total DNA stretch of 1414/1082
nucleotides were aligned together with 43 cyanobacterial species representing 14 major genera
of the order Oscillatoriales, obtained from GenBank (http://www.ncbi.nlm.nih.gov). The
multiple sequence alignments were performed using ClustalX, with standard gap opening and
extension penalties without gaps, and the aligned 16S rDNA gene sequences were used to
generate phylogenetic trees in MEGA 4.0. The phylogenetic relation of the cyanobacterial 16S
rDNA genes were compared; (1) the distance method by neighbour-joining (NJ), (2) maximum
parsimony (MP), and (3) the likelihood method by maximum-likelihood (ML). The
evolutionarily distant cyanobacterium Nostoc punctiforme PCC73102 (GenBank Acc. No.
AF027655) from the order Nostocales was used as an outgroup.
Extraction and Isolation
Approximately 64.5 g (dry weight) of the alga was extracted repeatedly with CH2Cl2–MeOH
(2:1) to yield 1.15 g of crude extract. The extract was fractionated by VLC using a stepwise
gradient with solvents of increasing polarity, from 100% hexanes to 100% MeOH. The polar
fractions eluting with 3:1 EtOAc-MeOH and 100% MeOH possessed activity against the H-460
cell line. These were further fractionated by RP solid phase extraction on Strata C18-E 500 mg
cartridges using a stepwise gradient from 10% MeOH–H2O to 100% MeOH. Further
purification was carried out via RP HPLC [Phenomenex Synergy-Hydro (4 μm particles, 21.2
× 250 mm), gradient elution from 45% CH3CN–H2O to 75% CH3CN–H2O over 30 min]
yielding the tumonoic acids D (1, 19.6 min, 1.8 mg), E (2, 14.2 min, 1.7 mg), F (3, 24.5 min,
3.4 mg), G (4, 28.6 min, 8.0 mg), H (5, 31.1 min, 1.1 mg), I (6, 32.7 min, 5.5 mg), and A (7,
18.3 min, 7.6 mg), and a mixture containing lyngbyastatins 1 and 3 (33.8 mg, 15-17 min).
Tumonoic acid D (1): colorless oil; [α]D −24.3 (c 0.81, MeOH); IR (neat) νmax 2957, 2927,
2856, 1725, 1614, 1468, 1447, 1195 cm−1; 1H NMR (CDCl3, 500 MHz) and 13C NMR
(CDCl3, 75 MHz) data, see Table 1; HRESI(+)MS m/z [M+H]+ 284.2211 (calcd for
C16H30NO3, 284.2220).
Tumonoic acid E (2): colorless oil; [α]D −24.8 (c 0.94, MeOH); IR (neat) νmax 3381, 2960,
2927, 2874, 1718, 1619, 1448, 1201 cm−1; 1H NMR (CDCl3, 500 MHz) and 13C NMR
(CDCl3, 75 MHz) data, see Table 1; HRESI(+)MS m/z [M+H]+ 326.2321 (calcd for
C18H32NO4, 326.2326).
Tumonoic acid F (3): colorless oil; [α]D −173.3 (c 1.62, MeOH); IR (neat) νmax 2959, 2927,
2856, 1746, 1626, 1461, 1461, 1373, 1238, 1195 cm−1; 1H NMR (CDCl3, 500 MHz) and 13C
NMR (CDCl3, 75 MHz) data, see Table 1; HRESI(+)MS m/z [M+H]+ 384.2736 (calcd for
C21H38NO5, 384.2744).
Tumonoic acid G (4): colorless oil; [α]D −33.6 (c 0.69, MeOH); IR (neat) νmax 2961, 2927,
2858, 1744, 1640, 1617, 1459, 1263, 1193, 1098 cm−1; 1H NMR (CDCl3, 500 MHz) and 13C
NMR (CDCl3, 75 MHz) data, see Table 2; HRESI(+)MS m/z [M+H]+ 470.3106 (calcd for
C25H44NO7, 470.3112).
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Tumonoic acid H (5): colorless oil; [α]D −42.6 (c 0.69, MeOH); IR (neat) νmax 2963, 2928,
2855, 1741, 1642, 1610, 1463, 1427, 1208, 1192, 1023 cm−1; 1H NMR (CDCl3, 500 MHz)
and 13C NMR (CDCl3, 75 MHz) data, see Table 2; HRESI(+)MS m/z [M+H]+ 484.3254 (calcd
for C26H46NO7, 484.3269).
Tumonoic acid I (6): colorless oil; [α]D −40.6 (c 3.0, MeOH); IR (neat) νmax 2964, 2929,
2878, 1742, 1647, 1625, 1460, 1198, 1132 cm−1; 1H NMR (CDCl3, 500 MHz) and 13C NMR
(CDCl3, 75 MHz) data, see Table 2; HRESI(+)MS m/z [M+H]+ 498.3417 (calcd for
C27H48NO7, 498.3413).
It should be noted that for many of the tumonoic acids, a second, minor set of NMR signals
was observed (<10% height of major peaks in all cases). These were attributed to minor isomers
caused by cis-trans proline isomerization.
Absolute Configuration of the Proline Residues of Tumonoic Acids D-I
The tumonoic acids (∼0.1 mg each) were hydrolyzed in 6 N HCl at 110 °C for 18 h, and then
extracted twice with EtOAc. The aq layers were dried under a stream of N2 before derivatization
with 1-fluoro-2,-4-dinitrophenyl-5-L-valeryl-amide (FDVA) in acetone (50 μL) and 0.1 M
NaHCO3 (100 μL) in sealed vials at 90 °C for 5 min. The resulting solutions were analysed
using RP HPLC using an HP LiChrospher 100 RP-18 (5 μm, 4 × 125 mm) column, eluting
with 50% CH3CN–H2O at a flow rate of 0.8 mL/min. The L-proline derivative eluted at 7.7
min, with the D-proline derivative eluting at 8.9 min.
Chiral HPLC analysis
Isoleucic acids were synthesized according to literature methods.23 The organic layers from
the acid hydrolysates of 4, 5, and 6 were evaporated to dryness and then redissolved in 2 mM
CuSO4. Analysis was carried out using three separate conditions. Condition 1: 100% 2 mM
CuSO4, 0.8 mL/min, Phenomenex Chirex 3126 (4.6 × 250 mm) column; elution times (tR, min)
for standards: L-lactic acid (22.1), D-lactic acid (29.2) min. Condition 2: 12.5% CH3CN in 2
mM CuSO4, 0.8 mL/min, Phenomenex Chirex 3126 (4.6 × 250 mm) column; elution times
(tR, min) for standards: L-2-hydroxyisovaleric acid (7.8), D-2-hydroxyisovaleric acid (12.1) min.
Condition 3: 12.5% CH3CN in 2 mM CuSO4, 0.8 mL/min, Phenomenex Chirex 3126 (4.6 ×
50 mm) column; elution times (tR, min) for standards: L-allo-isoleucic acid (18.3), L-isoleucic
acid (21.4), D-allo-isoleucic acid (28.5), D-isoleucic acid (34.1).
The hydrolysates of 4, 5 and 6 were analysed by the methods above, revealing the presence of
L-lactic acid and D-allo-isoleucic acid in 4; L-2-hydroxyisovaleric acid and D-2-
hydroxyisovaleric acid in 5; and L-isoleucic acid and D-allo-isoleucic acid in 6.
To define the positions of the hydroxy acids in 5 and 6, both were separately derivatized using
L-(–)-α-methylbenzylamine using the following method: 0.2 mg of the natural product was
dissolved in 100 μL CH2Cl2, cooled to 0 °C, and solutions of L-(–)-α-methylbenzylamine (12
μL), triethylamine (12 μL), EDAC·HCl (18 μL), and DMAP (12 μL) (all solutions 5 mg/mL)
were added sequentially. The mixture was allowed to stir overnight, with LC-MS analysis
indicating complete conversion to the desired products. The crude products were evaporated
to dryness, resuspended in CH2Cl2, and washed sequentially with 0.1 M HCl, H2O, 1 M
NaHCO3, H2O, and brine. The organic layers were evaporated to dryness and the residues
resuspended in MeOH–1 M NaOH (1:1) and left to stir overnight at room temperature. The
MeOH was removed under N2, the aq residue acidified with 2 M HCl, and then extracted twice
with EtOAc. The EtOAc was removed under N2, the samples suspended in 2 mM CuSO4, and
analysed by the relevant chiral HPLC methods as described above, revealing the presence of
free D-2-hydroxyisovaleric acid in 5 and D-allo-isoleucic acid in 6.
Clark et al. Page 8
J Nat Prod. Author manuscript; available in PMC 2009 September 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Synthesis of tumonoic acid D epimers
Commercially available racemic 2-methyldecanoic acid (50 mg) was dissolved in 2 mL
CH2Cl2, cooled to 0 °C, and L-proline methyl ester (30 mg), triethylamine (30 mg), EDAC·HCl
(51 mg), and DMAP (33 mg) were added sequentially. The mixture was allowed warm to room
temperature over 30 min and then stirred for 18 h, with LC-MS analysis indicating complete
conversion to the desired products. The crude products were evaporated to dryness,
resuspended in EtOAc, the slurry filtered and then the organic solubles washed as above to
yield the crude product (52 mg). The mixture was then hydrolysed in EtOH–1 M NaOH (1:1)
overnight at room temperature. The aq layer was acidified with 1 M HCl, extracted twice with
EtOAc, and the organic layer evaporated to dryness to yield the epimeric acids 1 and 8 (40
mg).
The two epimeric products were separated by RP HPLC using a Phenomenex Jupiter (10 μm,
21 × 250 mm) column, eluting with 45% CH3CN–H2O at a flow rate of 4 mL/min to give
tumonoic acid D (1, 14.2 mg) and the unnatural epimer 8 (13.8 mg). Co-injections with natural
1 were used to confirm which was the natural isomer, using the following HPLC conditions:
HP LiChrospher 100 RP-18 (5 μm, 4 × 125 mm) column, eluting with 40% CH3CN–H2O at
a flow rate of 0.8 mL/min. Elution times (tR, min): 1 (27.5), 8 (31.7).
A small sub-sample of each of the synthetic tumonoic acids was hydrolysed at 110 °C in
dioxane–6 M HCl (1:1) for 18 h. The hydrolysate was extracted with EtOAc, the organic layer
reduced under vacuum, and the residue purified by HPLC using a Phenomenex Synergi-Hydro
(4 μm, 21 × 250 mm) column, eluting with a gradient from 50% CH3CN–H2O to 100%
CH3CN at a flow rate of 4 mL/min. The optical rotations of the purified methyldecanoic acids
were measured and compared with literature values.15 Compound 1 yielded (2S)-2-
methyldecanoic acid ([α]D +12.3 (CHCl3, c = 0.26); lit. +5.1°), while the unnatural epimer 8
gave (2R)-2-methyldecanoic acid ([α]D −9.8 (CHCl3, c = 0.32); lit. −5.1°).
epi-Tumonoic acid D (8): colorless oil; [α]D −120 (c 0.67, CDCl3); IR (neat) νmax 2958, 2930,
2857, 1736, 1642, 1601, 1468, 1450, 1333, 1191 cm−1; 1H NMR (CDCl3, 500 MHz) δH 9.26
(br s, COOH), 4.60 (d, J = 4.7 Hz, H-2′), 3.63 (br t, J = 8.6 Hz, H-5′a), 3.53 (ddd, J = 9.2, 8.7,
6.1 Hz, H-5′b), 2.57 (dq, J = 6.8, 6.6 Hz, H-2), 2.41 (m, H-3′a), 2.03 (m, H-3′b), 2.01 (m, H-4′),
1.67 (m, H-3a), 1.41 (m, H-3b), 1.28-1.25 (m, H-4 – H-9), 1.15 (d, J = 6.6 Hz, 2-Me), 0.87 (t,
J = 6.8 Hz, H-10); 13C NMR (CDCl3, 75 MHz) δC 179.1 (C-1), 172.8 (C-1′), 59.9 (C-2′), 47.7
(C-5′), 38.1 (C-2), 33.5 (C-3), 31.8 (C-9), 29.6, 29.4, 29.2 (C5 – C-7), 27.5 (C-4), 27.4 (C-3′),
24.8 (C-4′), 22.6 (C-9), 17.2 (2-Me), 14.0 (C-10); ESI(+)MS m/z 284 [M+H]+.
Biological Activity
All metabolites were tested for activity in antimalarial,24 antileishmania,25 anti-Chagas,26
cytotoxicity (NCI-H460 lung tumor,27,28 L1210, Colon 38, H-116, H-125M, CEM, and CFU-
GM cell lines29), antibacterial (MRSA),30 and quorum sensing assays. Procedures for all
assays except quorum sensing are given in the appropriate references.
Quorum sensing assays were carried out using marine broth (MB) containing 1 g yeast extract
and 5 g peptone per liter synthetic seawater (Instant Ocean). For agar plates, 15 g agar (USB)
per L of H2O was used. 4-Bromo-5-(bromomethylene)-2-(5H)-furanone was synthesized as
reported previously.31 The 3-oxohexanoylhomoserine lactone (OHHL) is commercially
available (Sigma-Aldrich, Lot # 102K3851).
Vibrio harveyi BB120 produces bioluminescence in response to the autoinducers HAI-1, AI-2,
and CAI-1. V. harveyi was cultured in MB at 28 °C while shaking. An overnight culture of V.
harveyi BB120 in MB was diluted to an OD600 of 0.1. An aliquot (100 μL) of the diluted culture
was added to 5 mL of MB. Test compounds dissolved in DMSO were added to the wells of an
Clark et al. Page 9
J Nat Prod. Author manuscript; available in PMC 2009 September 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
opaque microtiter plate (Nunc A/S, Denmark; 0.0076 to 250 μM final concentration; 0.5 %
DMSO concentration; negative control = DMSO alone). The synthesized brominated furanone
was utilized as a positive control for inhibition of luminescence (0.0076 to 250 μM). The diluted
V. harveyi culture was added to the wells and mixed thoroughly. The plates were incubated for
4 h and read on a Packard Lumicount microtiter plate reader (Packard, UK). Relative
luminescence units were normalized by the optical density (600 nm) values obtained by
transferring 100 μL to a clear bottom microtiter plate.
Escherichia coli JB525 is E. coli MT102 harboring the gfp plasmid pJBA132. This mutant
produces an unstable green fluorescent protein in response to a C6-C8 N-acylhomoserine
lactone autoinducer. E. coli JB525 was cultured in LB4 broth at 30 °C. Inhibition of
fluorescence was determined using a method modified from Anderson et al.16 An overnight
culture of E. coli JB525 in LB4 broth was diluted to an OD450 of 0.25 with fresh media. Test
compounds dissolved in DMSO, or DMSO alone, were added to the wells of an opaque
microtiter plate (Nunc A/S, Denmark; 32 nM OHHL; 0.0076 to 250 μM test compounds; 1 %
DMSO concentration). The diluted E. coli culture was added to the wells and mixed thoroughly.
The plates were incubated with shaking at 30 °C for 90 min. Fluorescence was determined
using a Packard Fluorocount microtiter plate reader (λ=480 nm excitation, λ=515 nm
emission). Relative fluorescence values were normalized by optical density values obtained
by transferring 100 μL to a clear bottom microtiter plate (λ=450 nm, SpectraMax Multimode
Microplate Reader, Molecular Devices).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Structures of tumonoic acids D-I (1-6), A (7), and epi-tumonoic acid D (8). Configurations for
the fatty acid portions of 2-6 are relative only.
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Figure 2.
Elucidation of planar structures of tumonoic acids D-I (1-6). COSY correlations are indicated
by bolded bonds, while key HMBC correlations are designated by arrows (proton to carbon).
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Figure 3.
Phylogenetic relationships of filamentous marine cyanobacteria from 16S rDNA nucleotide
sequences, including new sequences from Blennothrix cantharidosmum and Schizothix sp.,
determined in this study (performed using partial 1,082 nucleotide sequence).
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